Over 100 million American adults and 1.5 billion persons worldwide¹ experience chronic pain—and more than 40% of those who report moderate to severe pain are not getting satisfactory relief.² The total annual incremental cost of health care due to pain ranges from $560 billion to $635 billion in the United States, which combines the medical costs of pain care and the economic costs related to disability days and lost wages and productivity.¹ Overall, workers lost an average of 4.6 hours per week of productive time due to a pain condition. Headaches lead to the most lost productivity, followed by back pain and arthritis.²

The treatment of pain is a complex problem that may require multiple medications. Use of oral medications can be limited due to drug interactions, adverse effects (e.g., drowsiness, etc), and potential addictions.

The science of compounding allows a compounding pharmacy to combine multiple ingredients into individualized, topically applied creams. These doctor-specified formulations offer an important additional therapy or alternative for many chronic pain sufferers. Applied topically, compounded pain formulations drive expertly blended prescription strength medications through the skin and directly to the source of pain. The active ingredients locally target the pain and limit absorption into the blood stream.³

DermaTran compounding pharmacies specialize in the treatment of pain. We employ a Care Model^SM based on more than 30 years of experience. Our Care Model^SM is designed to:

• Assist physicians in formulating compounded prescription creams tailored to each patient’s specific needs
• Personalized patient services to assist patients with insurance verification and claims processing
• Ensures the patient knows how to use their prescription correctly with an emphasis on compliance and adherence

The goal of the DermaTran Care Model^SM is to partner our clinicians with patients and their physicians to determine the most appropriate compounded prescription to bring about positive patient outcomes.